AbbVie’s $10.9B Acquisition, Nasdaq-100 Rebalance Spark Overnight Volatility
AbbVie’s recent acquisition of a biopharmaceutical company for $10.9 billion has sent shockwaves through the market, triggering significant overnight volatility. The deal, aimed at bolstering AbbVie’s pipeline and enhancing its position in the competitive healthcare…